These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30171664)

  • 1. The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data.
    Bengtsson B; Heijl A; Johannesson G; Andersson-Geimer S; Aspberg J; Lindén C
    Acta Ophthalmol; 2018 Sep; 96(6):557-566. PubMed ID: 30171664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study.
    King AJ; Hudson J; Azuara-Blanco A; Burr J; Kernohan A; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; Davidson T; Vale L; MacLennan G;
    Ophthalmology; 2024 Jul; 131(7):759-770. PubMed ID: 38199528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial.
    Bengtsson B; Heijl A
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5611-5615. PubMed ID: 27768797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study.
    Lindén C; Heijl A; Jóhannesson G; Aspberg J; Andersson Geimer S; Bengtsson B
    Acta Ophthalmol; 2018 Sep; 96(6):567-572. PubMed ID: 30242986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial.
    Bengtsson B; Lindén C; Heijl A; Andersson-Geimer S; Aspberg J; Jóhannesson G
    Acta Ophthalmol; 2022 Mar; 100(2):e455-e462. PubMed ID: 34327833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial.
    Katz LJ; Steinmann WC; Kabir A; Molineaux J; Wizov SS; Marcellino G;
    J Glaucoma; 2012 Sep; 21(7):460-8. PubMed ID: 21543992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.
    King AJ; Fernie G; Azuara-Blanco A; Burr JM; Garway-Heath T; Sparrow JM; Vale L; Hudson J; MacLennan G; McDonald A; Barton K; Norrie J
    Br J Ophthalmol; 2018 Jul; 102(7):922-928. PubMed ID: 29074496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
    Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Barton K; Wormald R; Morris S; Hunter R; Rubin G; Buszewicz M; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):593-598. PubMed ID: 28903966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
    Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
    Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up of the tube versus trabeculectomy study.
    Gedde SJ; Schiffman JC; Feuer WJ; Herndon LW; Brandt JD; Budenz DL;
    Am J Ophthalmol; 2009 Nov; 148(5):670-84. PubMed ID: 19674729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology.
    Garway-Heath DF; Lascaratos G; Bunce C; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Jan; 120(1):68-76. PubMed ID: 22986112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.